Endomag wins Queen's Award

Saturday, 21 April, 2018

Endomag announced today that it has received the Queen’s Award for Enterprise in Innovation for 2018. The Award recognises the Company’s efforts in developing novel surgical tools for more accurate removal of breast cancer.

Endomag has developed a minimally invasive surgical guidance...

University Hospitals System Widens Use of Magseed Marker

Tuesday, 13 March, 2018

Endomag announced today that University Hospitals (UH), one of the leading healthcare systems in the US, providing high-quality, patient-centred cancer care at locations throughout Northeast Ohio, has expanded the use of its Magseed® marker technology at more sites within the UH system. Magseed...

World First for Magseed

Thursday, 22 February, 2018

Endomag announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to extend the indication of its Magseed® magnetic marker to include both the marking of soft tissue and long-term implantation. The Magseed marker has already been used in thousands of...

Endomag receives CE Mark for Magseed

Wednesday, 13 September, 2017

Endomag announced today that it has received CE Mark approval for Magseed®, a minimally invasive breast marker used to accurately guide surgeons during breast cancer removal. Magseed will be distributed throughout EMEA by Sysmex, as part of a new 5-year distribution deal for the Sentimag®...


Ochsner Health System adopts Magseed

Monday, 8 May, 2017

Endomag announced today that Ochsner Health System has adopted Magseed® as the standard of care for breast lesion localisation, having identified the system as simpler and more effective than alternative techniques. Magseed was chosen as the preferred alternative to wire localisation, based on...


Please select if you are based outside the U.S.A.


Endomag US

Please select if you are based in the U.S.A.